Indefinite Delivery Contract HHSF223201510031I

This indefinite delivery contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The $10 million master IDIQ contract, titled "Tobacco Products Pharmacology Study", is focused on regulatory and scientific efforts related to tobacco products under the FDA's purview. The contract has resulted in several firm fixed-price delivery orders to Battelle, valued at...

The Department of Health and Human Services Food and Drug Administration awarded a single award Indefinite Delivery Indefinite Quantity contract to Labstat International Inc. to provide tobacco laboratory analysis and engineering services. The contract has a potential value of $45 million over five one-year ordering periods. Three firm fixed price delivery orders have been awarded against the contract to date, including for new smoking regimen services generating and quantitating tobacco smoke...

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Lovelace Biomedical Research Institute with a potential value of $25 million. To date, two firm fixed price delivery orders have been awarded against the contract. Task Order 1, valued at $3.8 million, tasks Lovelace Biomedical Research Institute to determine if reductions in biomarkers of exposure and potential harm are proportional to reductions in cigarette smoking...

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to the non-profit Research Triangle Institute (RTI) International. The contract, valued up to $2,500,000, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract includes two firm fixed-price delivery orders issued to date. The first...

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Northstar Technology Corp., a woman-owned small business. The contract has a total ceiling value of $1,000,000 and was set aside for the 8(a) small business program. The purpose of the contract is to acquire tobacco products for testing and analysis by the FDA. Under this IDV, Northstar has been issued several firm-fixed price delivery orders to provide a variety of tobacco...

The U.S. Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, valued at $5 million, to Labstat International Inc., a Canadian for-profit limited liability company, to provide tobacco analysis laboratory services over a 5-year period. This IDIQ contract allows the FDA to issue multiple firm fixed-price delivery orders for chemical, physical, and microbiological testing of tobacco, e-cigarette, cannabis, and CBD products in support of...

The Indefinite Delivery Contract (IDC) 75F40118D10043 was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Battelle Memorial Institute, doing business as Battelle, a nonprofit organization and manufacturer of goods. The contract provides $2,500,000.00 in ceiling value for Engineering Analysis Laboratory Services for ENDS (electronic nicotine delivery systems) and Other Newly Deemed Tobacco Products. This IDC is a multiple award vehicle under the broader...

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...